Skip to main content

How Dangerous Bacteria Survive

Illustration of Streptococcus pneumoniae bacterria

 

A collaborative team of scientists, including researchersGoethe University Frankfurt, has conducted research revealing how Streptococcus pneumoniae selectively captures the host sugar sialic acid as soon as it is released from human cells, providing new insights into how the bacterium establishes itself in the upper respiratory tract.

Streptococcus pneumoniae (S. pneumoniae) is a bacterium that causes millions of infections worldwide every year. It can cause illnesses ranging from common ear infections to dangerous diseases such as pneumonia and meningitis. Young children, older adults and other vulnerable people are especially at risk.

The noses and throats of many people are colonized by S. pneumoniae without them experiencing any symptoms; according to the Robert Koch Institute, this applies to 30 to 80 percent of children and 5 to 10 percent of adults. To survive there, S. pneumoniae must obtain nutrients by producing enzymes that release free sugars from the complex sugar chains coating the surface of eptihelial cells.

One of the main sugars released is known as sialic acid (N-acetylneuraminic acid), making it one of the most important nutrients for S. pneumoniae.

Researchers from Goethe University Frankfurt and University of St Andrews (UK) lead by Diamond Light Source (UK) and have been studying a S. pneumoniae protein called SatA, which captures free-floating sialic acid and subsequently shuttles it into the bacterium like a molecular spoon. Using protein crystallography, NMR and other techniques, they have built up a detailed picture of the interaction between SatA and sialic acid.

This work has revealed a surprising detail. In solution, free sialic acid exists as two forms, known as alpha and beta anomers, which differ only in the arrangement of atoms around a single carbon atom. Although the alpha form makes up only about 10% of the total, remarkably, SatA specifically binds the alpha anomer.

This observation has led the authors to speculate that S. pneumoniae specialises in the alpha form to gain a competitive advantage over other bacteria that colonize nose and throat competing for the same food source. Sialic acid is initially released from sugar chains in its alpha form and only later slowly converts into the beta form. Previous studies have shown that equivalent proteins from competing bacteria bind only the beta form. The competitive edge may therefore lie in the crucial moments immediately after release, when S. pneumoniae is ready to capture this valuable nutrient before its beta-specialising competitors can get to the plate.

Co-author Professor Dr Harald Schwalbe from Goethe University Frankfurt says: “The project documents the power of integrated structural biology, using X-rays and NMR to contribute to our understanding of molecular mechanisms.”

Dr Martin Walsh from Diamond Life Source says: “This study demonstrates the value of sustained collaborations between scientists at Diamond Light Source and leading academic groups. Using structural biology, the team uncovered an unexpected mechanism that may help explain how S. pneumoniae gains an advantage over competing bacteria during infection.”

 

Markus Bernards / Diamond Light Source